EMA prepares to begin publishing summary clinical trial results
This article was originally published in Scrip
The European Medicines Agency has launched a new version of its EU clinical trials database, EudraCT, that will allow sponsors to upload summary clinical trial results. The move is the first step in a process that will soon see these results made publicly available via the EU Clinical Trials Register (CTR), and is part of a wider drive to increase transparency in this area.
You may also be interested in...
The US company is bringing extra supplies of lopinavir/ritonavir into France but stresses that the combination treatment is not authorized for treating patients with the coronavirus.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
France is exploring the use of hydroxychloroquine and lopinavir/ritonavir in COVID-19, but only in hospitalized patients and in clinical trials, and has banned all exports of the products to avoid possible shortages.